Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

Last Close
15.99
Aug 10 • 4:00 PM ET Dollar change-0.01 Percentage change(-0.06%)
Aftermarket Close
15.68
Aftermarket • 5:00 PM ET Dollar change-0.31 Percentage change(-1.94%)
Index
-
Market Cap
464.99M
Enterprise Value
628.84M
Income
-
Sales
-
Book/sh
-4.96
Cash/sh
3.99
Dividend Est.
-
Dividend TTM
-
Dividend Ex-Date
-
Dividend Gr. 3/5Y
- -
Payout
-
Employees
63
IPO
Aug 07, 2026
P/E
-
Forward P/E
-
PEG
-
P/S
-
P/B
-
P/C
4.01
P/FCF
-
EV/EBITDA
-
EV/Sales
-
Quick Ratio
7.37
Current Ratio
7.37
Debt/Eq
-
LT Debt/Eq
-
Option/Short
No / No
EPS (ttm)
-
EPS next Y
-
EPS next Q
-
EPS this Y
-
EPS next Y
-
EPS next 5Y
-
EPS past 3/5Y
- -
Sales past 3/5Y
- -
EPS Y/Y TTM
-
Sales Y/Y TTM
-
EPS Q/Q
-
Sales Q/Q
-
Earnings
-
EPS/Sales Surpr.
- -
Insider Own
-
Insider Trans
-
Inst Own
-
Inst Trans
-
ROA
-
ROE
-
ROIC
-
Gross Margin
-
Oper. Margin
-
Profit Margin
-
SMA20
-0.03%
SMA50
-0.03%
SMA200
-0.03%
Trades
Shs Outstand
30.64M
Shs Float
-
52W High
16.05 -0.37%
52W Low
15.25 4.85%
Volatility
- -
ATR (14)
1.04
RSI (14)
-
Beta
-
Rel Volume
0.24
Avg Volume
1.76M
Volume
418,320
Perf Week
-
Perf Month
-
Perf Quarter
-
Perf Half Y
-
Perf YTD
1.52%
Perf Year
-
Perf 3Y
-
Perf 5Y
-
Perf 10Y
-
Recom
-
Target Price
-
Prev Close
16.00
Price
15.99
Change %
-0.06%
Blossomhill Therapeutics, Inc. is a biopharmaceutical company. It engages in the development of small molecule medicines for unmet medical needs in cancer treatment. The company was founded in June 2020 and is headquartered in San Diego, CA.
PhDJing Rong Jean Cui
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Schmid John P.DirectorAug 10 '26Buy16.006,00096,0006,000Aug 10 06:35 PM
Chen BihuaDirectorAug 10 '26Buy16.00312,5005,000,0003,614,034Aug 10 06:32 PM
Keyes Jason AChief Financial OfficerAug 10 '26Buy16.0070011,200700Aug 10 06:27 PM
Liptak Vincent PaulGeneral CounselAug 07 '26Buy15.802,50039,500109,212Aug 10 06:26 PM
Liptak Vincent PaulGeneral CounselAug 10 '26Buy16.002,20035,200111,412Aug 10 06:26 PM